ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,567 | -6.7% | 68,378 | -1.1% | 0.00% | – |
| Q2 2023 | $109,968 | +181.3% | 69,162 | +26.9% | 0.00% | – |
| Q1 2023 | $39,088 | +23.8% | 54,485 | 0.0% | 0.00% | – |
| Q4 2022 | $31,574 | -39.3% | 54,485 | -0.2% | 0.00% | – |
| Q3 2022 | $52,000 | -38.1% | 54,601 | -21.7% | 0.00% | – |
| Q2 2022 | $84,000 | -80.2% | 69,707 | -78.4% | 0.00% | – |
| Q1 2022 | $424,000 | -26.4% | 323,185 | -1.2% | 0.00% | – |
| Q4 2021 | $576,000 | -17.7% | 327,248 | +1.5% | 0.00% | – |
| Q3 2021 | $700,000 | -34.6% | 322,495 | +5.4% | 0.00% | – |
| Q2 2021 | $1,071,000 | -66.3% | 306,030 | -5.1% | 0.00% | -100.0% |
| Q1 2021 | $3,180,000 | -13.2% | 322,522 | -4.6% | 0.00% | 0.0% |
| Q4 2020 | $3,664,000 | +7.1% | 337,940 | +1.8% | 0.00% | 0.0% |
| Q3 2020 | $3,421,000 | -50.0% | 332,083 | +1.3% | 0.00% | -50.0% |
| Q2 2020 | $6,844,000 | +170.8% | 327,773 | +26.7% | 0.00% | +100.0% |
| Q1 2020 | $2,527,000 | -8.1% | 258,699 | +8.4% | 0.00% | 0.0% |
| Q4 2019 | $2,749,000 | +162.1% | 238,685 | +24.1% | 0.00% | – |
| Q3 2019 | $1,049,000 | -66.1% | 192,403 | -26.1% | 0.00% | -100.0% |
| Q2 2019 | $3,094,000 | +171.2% | 260,197 | +19.4% | 0.00% | – |
| Q1 2019 | $1,141,000 | +66.3% | 217,831 | -0.0% | 0.00% | – |
| Q4 2018 | $686,000 | -48.4% | 217,909 | -0.9% | 0.00% | – |
| Q3 2018 | $1,330,000 | +34.5% | 219,784 | +17.8% | 0.00% | – |
| Q2 2018 | $989,000 | +228.6% | 186,599 | +259.6% | 0.00% | – |
| Q1 2018 | $301,000 | +110.5% | 51,890 | +26.9% | 0.00% | – |
| Q4 2017 | $143,000 | +1.4% | 40,885 | +5.6% | 0.00% | – |
| Q3 2017 | $141,000 | +45.4% | 38,711 | 0.0% | 0.00% | – |
| Q2 2017 | $97,000 | -50.5% | 38,711 | -46.4% | 0.00% | – |
| Q1 2017 | $196,000 | -7.1% | 72,277 | -0.4% | 0.00% | – |
| Q4 2016 | $211,000 | -23.8% | 72,564 | +7.7% | 0.00% | – |
| Q3 2016 | $277,000 | +44.3% | 67,346 | +10.9% | 0.00% | – |
| Q2 2016 | $192,000 | – | 60,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |